Stephanie Earnshaw

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter

Filter by Year

Search Results

Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage

Software and computer interface

Aspirin, statins, or both therapies for primary prevention of myccardial infarction: A cost-utility analysis

Effect of including cancer mortality on the cost-effectiveness of aspirin for primary prevention in men

Mathematical programming modeling: An alternative to incremental cost-effectiveness analysis and budget impact analysis to optimize allocations of health care interventions

Using the coronary artery calcium score to guide statin therapy: A cost-effectiveness analysis

Cost effectiveness of 5-alpha reductase inhibitors for the prevention of prostate cancer in multiple patient populations

Factor VIII alloantibody inhibitors: Cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada

Model-based cost-effectiveness analyses for the treatment of acute stroke events: A review and summary of challenges

Estimating condition-related costs

Clinical and economic impacts of large volume delayed sampling and pathogen reduction technology platelet processing strategies in the United States

Estimating treatment-related costs

Comparing olanzapine and ziprasidone in the treatment of schizophrenia: a case study in modeling

Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis

Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: Implications of improved persistence with less frequently administered oral bisphosphonates

Pathway for the Development of Drugs to Treat Irritable Bowel Syndrome: From Molecule Identification Through Approval

Economic efficiency of genetic screening to inform the use of abacavir sulfate in the treatment of HIV

Alternative interventions

Design of a survey to inform state health decision making: a collaborative effort